ロピナビル・リトナビル

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
 Cao B, et al.〔N Engl J Med. 2020 May 7;382(19):1787-1799〕（査読済み）


Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
 Hung IF, et al.〔Lancet. 2020 May 30;395(10238):1695-1704〕（査読済み）